{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:57:13Z","timestamp":1781326633628,"version":"3.54.1"},"reference-count":27,"publisher":"Japan Atherosclerosis Society","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5551\/jat.66114","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:09:48Z","timestamp":1781129388000},"source":"Crossref","is-referenced-by-count":0,"title":["Distribution of Lipoprotein(a) Levels Among Children with Elevated Low-Density Lipoprotein Cholesterol Identified Through Universal Pediatric Lipid Screening"],"prefix":"10.5551","author":[{"given":"Ryosuke","family":"Tani","sequence":"first","affiliation":[{"name":"Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsufumi","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoko","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iwase","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kusaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Ying Fu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hyogo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tada H, Kojima N, Yamagami K, Takeji Y, Sakata K, Usui S, Kawashiri MA, and Takamura M: Association between lipoprotein (a) Levels and coronary artery disease (CAD) among Patients with or without CAD family history. J Lipid Atheroscler, 2024; 14: 120-127","DOI":"10.12997\/jla.2025.14.1.120"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Wilson DP, Jacobson TA, Jones PH, Koschinsky ML, McNeal CJ, Nordestgaard BG, and Orringer CE: Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol, 2019; 13: 374-392","DOI":"10.1016\/j.jacl.2019.04.010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) de Boer LM, Wiegman A, Kroon J, Tsimikas S, Yeang C, Peletier MC, Revers A, Kastelein JJP, Zwinderman AH, and Hutten BA: Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study. Lancet Diabetes Endocrinol, 2023; 11: 667-674","DOI":"10.1016\/S2213-8587(23)00156-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mach F, Koskinas KC, Roeters van Lennep JE, Tokg\u00f6zo\u011flu L, Badimon L, Baigent C, Benn M, Binder CJ, Catapano AL, De Backer GG, Delgado V, Fabin N, Ference BA, Graham IM, Landmesser U, Laufs U, Mihaylova B, Nordestgaard BG, Richter DJ, and Sabatine MS; ESC\/EAS Scientific Document Group: 2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias. Eur Heart J, 2025; 46: 4359-4378","DOI":"10.1016\/j.atherosclerosis.2025.120479"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, and Khera AV: Lp (a)(lipoprotein [a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank. Arterioscler Thromb Vasc Biol, 2021; 41: 465-474","DOI":"10.1161\/ATVBAHA.120.315291"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Berman AN, Biery DW, Besser SA, Singh A, Shiyovich A, Weber BN, Huck DM, Divakaran S, Hainer J, Kaur G, Blaha MJ, Cannon CP, Plutzky J, Januzzi JL, Booth JN, L\u00f3pez JAG, Kent ST, Nasir K, Di Carli MF, Bhatt DL, and Blankstein R: Lipoprotein(a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease. J Am Coll Cardiol, 2024; 83: 873-886","DOI":"10.1016\/j.jacc.2023.12.031"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Harada-Shiba M, Ohtake A, Sugiyama D, Tada H, Dobashi K, Matsuki K, Minamino T, Yamashita S, and Yamamoto Y: Guidelines for the diagnosis and treatment of pediatric familial hypercholesterolemia 2022. J Atheroscler Thromb, 2023; 30: 531-557","DOI":"10.5551\/jat.CR006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, Von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokg\u00f6zo\u011flu LS, and Catapano AL: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J, 2022; 43: 3925-3946","DOI":"10.1093\/eurheartj\/ehac361"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Greco A, Finocchiaro S, Spagnolo M, Faro DC, Mauro MS, Raffo C, Sangiorgio G, Imbesi A, Laudani C, Mazzone PM, Ammirabile N, Giacoppo D, Landolina D, and Capodanno D: Lipoprotein(a) as a pharmacological target: premises, promises, and prospects. Circulation, 2025; 151: 400-415","DOI":"10.1161\/CIRCULATIONAHA.124.069210"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Matsunaga K, Mizobuchi A, Ying Fu H, Ishikawa S, Tada H, Kawashiri MA, Yokota I, Sasaki T, Ito S, Kunikata J, Iwase T, Hirao T, Yokoyama K, Hoshikawa Y, Fujisawa T, Dobashi K, Kusaka T, and Minamino T: Universal screening for familial hypercholesterolemia in children in Kagawa, Japan. J Atheroscler Thromb, 2022; 29: 839-849","DOI":"10.5551\/jat.62780"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tani R, Matsunaga K, Inoue T, Nishioka K, Irie K, Kondo S, Iwase T, Fu HY, Ito S, Sasaki T, Yoshida S, Yokota I, Hoshikawa Y, Yokoyama K, Fujisawa T, Tada H, Takamura M, Kusaka T, and Minamino T: Potential barriers to reverse cascade screening combined with universal cholesterol screening for paediatric familial hypercholesterolemia: focus on second-degree relatives of a proband. Rare Dis Orphan Drugs J, 2025; 4: 11","DOI":"10.20517\/rdodj.2024.50"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Fu HY, Matsunaga K, Inoue T, Tani R, Funatsuki K, Iwase T, Kondo S, Nishioka K, Ito S, Sasaki T, Yokota I, Hoshikawa Y, Yokoyama K, Fujisawa T, Kawashiri MA, Tada H, Takamura M, Kusaka T, and Minamino T: Improved efficiency of the clinical diagnostic criteria for familial hypercholesterolemia in children: a comparison of the Japan Atherosclerosis Society Guidelines of 2017 and 2022. J Atheroscler Thromb, 2024; 31: 1048-1057","DOI":"10.5551\/jat.64513"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tani R, Matsunaga K, Inoue T, Nishioka K, Irie K, Kondo S, Iwase T, Fu HY, Ito S, Sasaki T, Yoshida S, Yokota I, Hoshikawa Y, Yokoyama K, Fujisawa T, Tada H, Takamura M, Kusaka T, and Minamino T: Utility of discrepancies between Friedewald and martin equations in predicting pathogenic variants of familial hypercholesterolemia in children. Circ J, 2025; 89: 1190-1196","DOI":"10.1253\/circj.CJ-24-0928"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Matsunaga K, Harada-Shiba M, Yamashita S, Tada H, Uda A, Mori K, Yoshimura M, Inoue S, Kamae I, Yokoyama S, and Minamino T: A cost-effectiveness analysis for the combination of universal screening at 9-10 years old and reverse cascade screening of relatives for familial hypercholesterolemia in Japan. J Atheroscler Thromb, 2025; 32: 962-981","DOI":"10.5551\/jat.65181"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Miida T, Hirayama S, Fukushima Y, Hori A, Ito S, Hinata M, Wakita M, Tabata H, Tamura Y, Watada H, Kawamori R, Vesper HW, and Cobbaert CM: Harmonization of lipoprotein(a) immunoassays using A serum panel value assigned with the IFCC-endorsed mass spectrometry-based reference measurement procedure as A first step towards apolipoprotein standardization. J Atheroscler Thromb, 2025; 32: 580-595","DOI":"10.5551\/jat.65238"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tada H, Kawashiri MA, Nomura A, Teramoto R, Hosomichi K, Nohara A, Inazu A, Mabuchi H, Tajima A, and Yamagishi M: Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. J Clin Lipidol, 2018; 12: 1436-1444","DOI":"10.1016\/j.jacl.2018.08.006"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yamamoto T, Shimojima K, Ondo Y, Imai K, Chong PF, Kira R, Amemiya M, Saito A, and Okamoto N: Challenges in detecting genomic copy number aberrations using next-generation sequencing data and the eXome hidden Markov model: a clinical exome-first diagnostic approach. Hum Genome Var, 2016; 3: 16025","DOI":"10.1038\/hgv.2016.25"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tada H, Kawashiri MA, Yoshida T, Teramoto R, Nohara A, Konno T, Inazu A, Mabuchi H, Yamagishi M, and Hayashi K: Lipoprotein(a) in familial hypercholesterolemia with proprotein convertase subtilisin\/kexin type 9 (PCSK9) gain-of-function mutations. Circ J, 2016; 80: 512-518","DOI":"10.1253\/circj.CJ-15-0999"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kronenberg F, Bedlington N, Ademi Z, Geant\u0103 M, Silberzahn T, Rijken M, Kaal A, Harada-Shiba M, Chen Z, Thanassoulis G, Eliasen B, Eisel\u00e9 JL, Wiegman A, Ballantyne CM, Broome E, Calabr\u00f2 M, Corral P, Dol A, Donato LJ, Evans E, Funabashi S, Gouni-Berthold I, Ibarluzea IG, Johnson N, Lane J, Mora S, Nordestgaard BG, Pe\u0107in I, Kaal-Poppelaars R, Langlois MR, Ray KK, Rodenbach A, Santos RD, Stroes ESG, Tada H, Vrabl\u00edk M, Winokur M, Yoshida M, Nicholls SJ, and Daccord M: The brussels international declaration on lipoprotein(a) testing and management. Atherosclerosis, 2025; 406: 119218","DOI":"10.1016\/j.atherosclerosis.2025.119218"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Gannag\u00e9-Yared MH, Lahoud C, Younes N, Chedid R, and Sleilaty G: Prevalence and status of lipoprotein (a) among Lebanese school children. Sci Rep, 2020; 10: 20620","DOI":"10.1038\/s41598-020-77689-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Giussani M, Orlando A, Tassistro E, Torresani E, Lieti G, Patti I, Colombrita C, Bulgarelli I, Antolini L, Parati G, and Genovesi S: Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents? Ital J Pediatr, 2024; 50: 161","DOI":"10.1186\/s13052-024-01732-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Marcovina SM: Lipoprotein (a): a genetically determined risk factor for Cardiovascular disease. Crit Rev Clin Lab Sci, 2023; 60: 560-572","DOI":"10.1080\/10408363.2023.2229915"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Cobbaert C, Deprost L, Mulder P, Rombaut K, Gijsels G, and Kesteloot H: Pubertal serum lipoprotein (a) and its correlates in Belgian schoolchildren. Int J Epidemiol, 1995; 24: 78-87","DOI":"10.1093\/ije\/24.1.78"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rosenson RS, L\u00f3pez JAG, Monsalvo ML, Wu Y, Wang H, and Marcovina SM: Quantification of LDL-cholesterol corrected for molar concentration of lipoprotein(a). Cardiovasc Drugs Ther, 2024; 38: 191-197","DOI":"10.1007\/s10557-022-07407-y"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) de Boer LM, Reijman MD, Hutten BA, and Wiegman A: Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study. J Clin Lipidol, 2023; 17: 415-419","DOI":"10.1016\/j.jacl.2023.03.010"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Johansen AK, Bogsrud MP, Thoresen M, Christensen JJ, Narverud I, Langslet G, Svilaas T, Retterst\u00f8l K, and Holven KB: Lipoprotein(a) in children and adolescents with genetically confirmed familial hypercholesterolemia followed up at a specialized lipid clinic. Atheroscler Plus, 2024; 57: 13-18","DOI":"10.1016\/j.athplu.2024.06.002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kindborg G, Eriksson Hogling D, H\u00e4bel H, Yan J, Hallerb\u00e4ck T, Lindhe \u00d6, Hagstr\u00f6m E, Andersson DP, Littmann K, and Brinck J: Major cardiovascular events in first-degree relatives of individuals with elevated plasma lipoprotein(a): a registry-based cohort study. Eur Heart J, 2025; ehaf677","DOI":"10.1093\/eurheartj\/ehaf677"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66114\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:22:52Z","timestamp":1781324572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66114\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"URL":"https:\/\/doi.org\/10.5551\/jat.66114","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"66114"}}